Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

08 mai 2025 04h26 HE | Source: Research and Markets

Rett Syndrome Pipeline Analysis Report 2025: Comprehensive Insights Into 20+ Companies, 20+ Pipeline Drugs and the Therapeutics Landscape

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Rett Syndrome - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
28 févr. 2025 06h51 HE | Source: Research and Markets

Rett Syndrome Competitive Market Landscape Report 2024: 51 Molecules in Development - 1 Drug in the Pre-Registration, Trofinetide is Approved in the US and is Being Developed in the EU in Phase III

Dublin, Feb. 28, 2025 (GLOBE NEWSWIRE) -- The "Rett Syndrome: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven overview of the...
28 févr. 2024 12h14 HE | Source: Research and Markets

Rett Syndrome Treatment Advancements: Latest Pipeline Insight Report 2024 Reveals Growing Number of Therapeutic Candidates

Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Rett Syndrome - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
18 mai 2023 05h28 HE | Source: MAXIMIZE MARKET RESEARCH PRIVATE LIMITED

Rett Syndrome Market is expected to hit USD 515.06 Mn by 2029 at a CAGR of 10.23 percent – says Maximize Market Research

Pune, May 18, 2023 (GLOBE NEWSWIRE) -- A global Healthcare research and business consulting firm, Maximize Market Research, has published a market intelligence report on the “Rett Syndrome Market”....